NCT05173883View on ClinicalTrials.gov

A Phase 1 Clinical Study of CU-20401 in Chinese Healthy Population

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

November 2, 2023

Study Completion Date

November 2, 2023

Conditions
Healthy Subjects
Interventions
DRUG

injection ，CU-20401

Subcutaneous injection，cohort A 6 sites

DRUG

injection ，placebo

Subcutaneous injection，just one site

Trial Locations (1)

200030

Shanghai Xuhui Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Cutia Therapeutics（Wuxi）Co.,Ltd

INDUSTRY